🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to announce our world-class scientific advisory board as we work to innovate therapies for #braincancer. Welcome to our team Roger Stupp MD, David Reardon MD, Walter Stummer MD, and Mathias Senge MD! prnewswire.com/news-releases/… #glioblastoma

Excited to announce our Phase 1 #glioblastoma #clinicaltrial for non-invasive #sonodynamictherapy is now enrolling. We also received #FDA Orphan Drug and Fast Track designations. Learn how we aim to beat #braincancer. rb.gy/dcuowd #GBM #BTSM

The U.S. FDA granted fast track and orphan drug designations to Alpheus Medical’s CV-01 delivery of sonodynamic therapy for treatment of recurrent glioblastoma. Read story on Healio: bit.ly/3O64xwV

Glioblastoma is the most common and deadliest type of #braincancer. It’s time to change the narrative. Learn more about how we are working to change it with our non-invasive solution at alpheusmedical.com. #GBM #gbmday

.The Alpheus Group wins orphan drug and fast track designations to fight deadliest form of brain cancer #Oncology bioworld.com/articles/52096…

Excited to share that our #gbm trial is underway and 3 patients have been treated with our novel, non-invasive #SDT therapy! Thanks to our partners, we are changing the landscape of #braincancer treatment. Learn more at prn.to/3tjAwBS

Going to #SNO2024 in Houston? Come hear our exciting Phase 1/2 #FIH results for #BrainCancerTreatment and learn about our proprietary  #sonodynamictherapy (SDT) solution for #glioblastoma treatment. #CancerResearch #BrainCancer #NeuroOncology #BrainTumor #GlioblastomaResearch

Presenting Alpheus CV101 results at #SNO2024. This was a phase 1 trial proving safety and also showing prolonged survival in people with recurrent high grade glioma!

We’re thrilled to announce positive results from our Phase 1/2 #clinicaltrial in #glioblastoma patients, presented at #SNO2024! Our groundbreaking #sonodynamictherapy (SDT) shows promising safety and early efficacy in targeting this devastating disease. prn.to/40WWJHW

#gliobastloma is a devastating diagnosis, but recent early #clinicaltrial data on our proprietary #SDT treatment shows new promise for newly diagnosed #GBM patients. Read more shorturl.at/7Zlmw #braintumorresearch, #braintumorcommunity, #cancer #innovation